The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change and Cost Reduction Initiatives

10 Aug 2017 07:00

RNS Number : 5641N
Quadrise Fuels International PLC
10 August 2017
 

 10 August 2017

 

Quadrise Fuels International plc

("Quadrise", "QFI" or the "Company")

 

 Directorate Change and Cost Reduction Initiatives

 

Quadrise Fuels International plc (AIM: QFI) announces that in addition to its existing rigorous approach to cost management, the Company has taken a number of actions to further reduce costs, whilst retaining its ability to deliver its active projects and pursue business development opportunities in the power and marine markets.

 

Directorate Change

 

Hemant Thanawala has agreed to step down as Finance Director and will become a Non-executive Director, with immediate effect. This enables the Board to restructure and streamline the number of Executive Directors from three to two. The Company will retain its focus on sound cash management, allied with strong project accounting, led by the Financial Controller, David Scott, FCA. The Finance Director functions will be absorbed within the existing senior team.

 

Further Cost Reduction Initiatives

 

Mike Kirk, Executive Chairman, has agreed to reduce his cash salary by 50% with effect from 1st September 2017 with an uplift on the deferred element for potential future payment of 25%. In addition, the Non-executive Directors of the Company, including Mr Thanawala, have agreed to reduce their directors' fees to £24,000 per annum, with the balance being deferred, for potential future payment with an uplift of 25%.

 

The General Manager roles have been restructured to enable the three segments of Refinery, Power and Marine to be covered effectively by two General Managers. In addition, the laboratory personnel roles at the Quadrise Research Facility have been reduced by one.

 

The Company's advisers have also agreed to significant reductions in fees.

 

In total, these actions are expected to deliver annualised cash-cost savings in excess of £500,000, around 18% of the Company's underlying (non-project specific) annualised costs.

 

Business Development and Project Delivery

 

Quadrise continues to invest in its project delivery and business development capabilities. Maersk's decision to end the operational and LONO trial early, despite the positive results was clearly disappointing. However, it was based on a policy decision by Maersk to use low sulphur fuels, for IMO 2020 compliance and was not based on any issues with the MSAR® fuel - with Maersk having confirmed that good progress was made and no issues had arisen with the use of MSAR®.

 

Quadrise and many market commentators still believe that the use of high sulphur fuels in conjunction with Exhaust Gas Cleaning Systems, or scrubbers, will offer the lowest cost of compliance with the IMO 2020 sulphur regulations. We will continue to use the positive results of the trial, together with the interim LONO and inspection report from Wärtsilä to actively pursue other opportunities in the marine market.

 

In the power market, Quadrise has continued to invest significant senior management time into driving the project in Saudi Arabia forward and this is delivering substantive progress. A more comprehensive update will be provided in due course, but the project remains on track to commence later in 2017.

 

Mike Kirk, Executive Chairman, said:

 

"This has been a challenging period for Quadrise and we have made some important cost reductions to ensure that we can still actively pursue the significant opportunities for MSAR® in the power and marine markets.

 

The cost savings are designed to have no impact on our operational or business development capacity. As part of this process, Hemant has agreed to move into a Non-Executive role, so that we can continue to benefit from his experience and knowledge of the business. I would like to formally thank Hemant for his contribution to Quadrise over many years as the Finance Director and I look forward to working with him in his new role as a Non-Executive Director. I would also like to thank our non-executive directors and advisers for their support in the cost reduction initiatives.

 

We remain motivated and committed to delivering value to shareholders from our unique technology."

 

Notes to Editors 

 

QFI is the emerging supplier of MSAR® emulsion technology and fuel, enabling a low-cost alternative to heavy fuel oil (one of the world's largest fuels markets, comprising over 450 million tonnes per annum) in the global shipping, refining and power generation markets.

 

For further information, please refer to the Company's website at www.quadrisefuels.com or contact:

 

Quadrise Fuels International Plc

 

Mike Kirk, Executive Chairman

+44 (0)20 7031 7321

 

 

Nominated Adviser

 

Smith & Williamson Corporate Finance Limited

 

Dr Azhic Basirov

+44 (0)20 7131 4000

Ben Jeynes

Katy Birkin

 

 

 

Broker

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

 

Chris Burrows 

 

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Sara Powell

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAKPNELAXEFF
Date   Source Headline
10th Dec 20214:41 pmRNSSecond Price Monitoring Extn
10th Dec 20214:36 pmRNSPrice Monitoring Extension
6th Dec 20214:36 pmRNSPrice Monitoring Extension
1st Dec 20218:00 amEQSEdison Investment Research Limited: Quadrise Fuels International (QFI): Cleaner fuel, cleaner planet
26th Nov 20213:30 pmRNSResult of AGM
26th Nov 20217:00 amRNSAGM Statement
1st Nov 20215:00 pmRNSPosting of Annual Report and Notice of AGM
20th Oct 20215:45 pmRNSMorocco Travel Restrictions
5th Oct 20214:41 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
4th Oct 20217:00 amRNSFinal Results, Directorate Change & Notice of AGM
1st Oct 20217:00 amRNSTotal Voting Rights
24th Sep 20217:00 amRNSNotice of Results and Investor Presentation
23rd Sep 20217:00 amRNSUtah Project Update
20th Sep 20214:36 pmRNSPrice Monitoring Extension
3rd Sep 20212:30 pmRNSIssue of Share Options & Director/PDMR Dealing
2nd Sep 20214:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSPublication of bioMSAR Test Results
23rd Aug 20217:00 amRNSGreenfield Commercial Trial Agreement Extension
11th Aug 20217:00 amRNSUpdate on bioMSAR™ Testing
4th Aug 20217:00 amRNSUtah Project Update
30th Jul 20219:30 amRNSBlock Admissions
16th Jul 20214:40 pmRNSSecond Price Monitoring Extn
16th Jul 20214:35 pmRNSPrice Monitoring Extension
16th Jul 20211:15 pmRNSDirectorate Change
28th Jun 20217:00 amRNSUpdate on bioMSAR™ and MSAR® projects
17th May 20214:40 pmRNSSecond Price Monitoring Extn
17th May 20214:35 pmRNSPrice Monitoring Extension
4th May 20219:24 amRNSIssue of Equity
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
16th Apr 20214:40 pmRNSSecond Price Monitoring Extn
16th Apr 20214:35 pmRNSPrice Monitoring Extension
1st Apr 202112:50 pmRNSUpdate re Greenfield Commercial Trial Agreement
29th Mar 20217:00 amRNSInterim Results
25th Mar 20214:40 pmRNSSecond Price Monitoring Extn
25th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Mar 20217:00 amRNSResults of Open Offer
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSResults of Placing and Open Offer Launch
1st Mar 20214:41 pmRNSProposed Placing and Open Offer
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSFinal Issue of Convertible Securities
4th Feb 20214:41 pmRNSSecond Price Monitoring Extn
4th Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.